ANESTHETIC

ANESTHETIC

Anesthetic can be used not only to make the client more comfortable during their procedure but also to achieve more accurate results, as without anesthetizing the area, the client may try to contract their muscles resulting in pigment being implanted in the wrong area. A topical anesthetic should generally be applied both before and during treatment for maximum efficacy, depending on whether it is suitable for broken or unbroken skin. It is also important to let the client know that they may still feel discomfort, although it will be greatly reduced. The amount of anesthetic that you will need to use will be dependent on the individual. Clients with higher metabolisms, for example may process the anesthetic more quickly and therefore require more of it throughout the procedure. It is incredibly important that you are aware of the national guidelines regarding the use of anesthetics, and any use of prescription anesthetic deemed to be used inappropriately or illegally will result is prosecution. Please note that the client must purchase the anesthetics that will be used herself. 

USE OF TOPICAL ANESTHETIC
If choosing to use topical anesthetic creams to numb the area, they should be applied 30 minutes before commencement of treatment. Below is a quick guide on how to use a product, but you must follow manufacturers recommendations.

NUMBING CREAM
Cream is usually applied thickly to treatment area and covered with cling film. It can take 30-60 minutes for this cream to effectively numb the area. Emla contains 2 medicines called lidocaine and prilocaine that belong to a group of medicines called local anesthetics. Application of this cream will stop pain on the skin; however, you may still experience feelings of pressure and touch. It is common for the skin to look paler for a short time following the application of cream, some people may experience erythema and slight swelling.

Numbing cream should not be used if you are allergic to any of the following ingredients:

  • Lidocaine
  • Prilocaine
  • Polyoxymethylene
  • hydrogenated castor oil
  • Carbomer 974P
  • Sodium hydroxide
  • Purified water

DOCTOR permission should be sought before use on the following clients suffering with:

  • Anemia
  • Rare inherited illness called glucose-6-phosphate dehydrogenase deficiency
  • Methemoglobinemia (affects blood pigment levels)
  • Atopic dermatitis

Or using the following medications:

  • Sulphonamides (Synthetic bacteriostatic drugs that are effective in treating infections caused by gram-negative/positive microorganisms. They are used in treating urinary tract infections)
  • Other local anesthetics
  • Mexiletine or amiodarone (treatment for uneven heartbeat)

The above information should be checked at the consultation stage of treatment. Emla cream is not recommended for use close to the eye area and never during any eye procedure. If using around the mouth area, ensure ingestion of product does not take place. 

AMNITOP 4% 
The cream will numb the area within 30 minutes without the need for a cling film covering. However, Amnitop is a vasodilator which means even though the capillaries will be more visible, coagulation may be inhibited causing a higher current to be used to achieve effective cauterization. Amnitop Gel is a white semi-transparent gel containing 4% active ingredient of tetracaine. Amnitop gel should be applied to the area to be anesthetized and covered with an airtight dressing (cling film can be used). The numbing effect of Amnitop gel usually lasts for 4 to 6 hours after a 30 to 45-minute application. It is usual to see slight flushing of the skin in the treated area due to widening of the small blood vessels (erythema). 

Some clients may experience: 

  • Swelling (oedema) of the skin in the treated area
  • Itching of the skin in the treated area
  • Blistering of the skin at the site of application may occur very rarely. If this happens the gel should be removed from the skin immediately

If any of these reactions occur the use of Amnitop as a topical anesthesia is not recommended as not only, will it cause a skin irritation it may also inhibit the effectiveness of micro-pigmentation treatment.

Amnitop should not be used if you are allergic to any of the following ingredients:

  • 4% w/w of tetracaine
  • Purified water
  • Sodium chloride
  • Potassium phosphate
  • Xanthan gum (E415)
  • Sodium hydroxide and sodium methyl and propyl-p-hydroxybenzoates (E217 & E219)

DOCTOR permission should be sought before use on the following clients suffering with:

  • Epilepsy
  • Allergies to local anesthetics
  • Heart conditions

This medicine is not known to affect other medicines. Amnitop cream is not recommended for use close to the eye area. If using around the mouth area, ensure ingestion does not take place.

ASPIRIN OR NSAIDS
Clients are often tempted to take pain-reducing medication before treatment. Aspirin and NSAIDS have anti-coagulant properties and therefore will affect the clotting mechanism and result in a higher current than necessary being used which will cause more trauma and increase the risk of bleeding or bruising.